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Abstract: Fibre supplementation can potentially reduce energy intake and contribute to weight
loss. The mechanism may be reduced frequency of eating, resulting in reduced food consumption.
The objective of this research was to determine the effectiveness of fibre supplementation with
PolyGlycopleX® (PGX®), on body weight and composition, frequency of eating and dietary intake
in 118 overweight adults. In a three-arm, parallel, blind, randomised controlled trial participants
were randomised to one of three groups; 4.5 g PGX as softgels (PGXS), 5 g PGX granules (PGXG) or
5 g rice flour (RF) control. Prior to supplementation and at 12 weeks, participants captured before
and after images of all food and beverages consumed within 4 days using a mobile food record app
(mFR). The mFR images were analysed for food group serving sizes and number of eating occasions.
In the PGXG group, intention-to-treat analysis showed there was a significant reduction in waist
circumference (2.5 cm; p = 0.003). Subgroup analysis showed that PGXG supplementation at the
recommended dose resulted in a reduction in body weight (−1.4 ± 0.10 kg, p < 0.01), body mass index
(BMI) reduction (−0.5 ± 0.10, p < 0.01), reduced number of eating occasions (−1.4 ± 1.2, p < 0.01)
and a reduced intake of grain food (−1.52 ± 1.84 serves, p = 0.019). PGXG at the recommended dose
resulted in a reduction in weight and BMI which was significantly greater than that for RF (p = 0.001).
These results demonstrate the potential benefits of PGX fibre in controlling frequency of eating and in
weight loss.
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1. Introduction
The burden of chronic disease in many countries is increasing concomitant with the percentage
of the population with a high body mass index (BMI) [1]. Providing tools to improve the healthiness
of the food environment and assisting people to make healthy food choices are important in the
prevention of excessive weight gain [1].
Dietary pattern evidence has shown that higher dietary quality i.e. consumption of mainly whole
grains, vegetables, fruit, nuts, legumes, seafood, plant protein and low-fat dairy leads to marked
reductions in all-cause, cardiovascular disease and cancer mortality [2,3]. Similarly, a healthy dietary
pattern which includes consumption of fruits, vegetables, grains, combined with a lower intake of
sweets, red meat and processed meat, lowers the risk of developing colorectal cancer [4].
Evidence supports the role of dietary fibre in improving metabolic health. A higher intake of
fibre is associated with increased satiety and reduced energy intake and therefore may be important in
obesity management [5–11].
Total fibre is the sum of both dietary fibre (complete, intrinsic non-digestible plant carbohydrates,
lignin) and functional fibres (non-digestible carbohydrates that have been isolated but still have
beneficial physiological effects) [12]. What constitutes a ‘beneficial physiological effect’ and the level of
evidence required for this to be substantiated remains unspecified [13]. Solubility or the ability of a fibre
to dissolve in water will affect water holding capacity, viscosity and fermentability [11]. The properties
of fibre that are associated with appetite, energy intake and body weight include solubility [11].
Solubility remains a common classification technique, although it has been suggested that fibres should
be categorised according to functional properties such as viscosity and fermentability [14], since not all
fibre is equal in delivering a beneficial physiological effect.
PolyGlycopleX (PGX) is a commercial functional fibre complex, manufactured by a proprietary
process (EnviroSimplex®) from three dietary fibres: konjac glucomannan, sodium alginate, and
xanthan gum [9]. PGX is a soluble viscous non-starch polysaccharide complex that has been identified
as contributing to improved satiety, lipidaemia and glycaemia [8–10,15,16].
In the modern food environment both portion size and frequency of eating have increased in
the population [17]. Mattes [17] has suggested that increased frequency of eating is a major factor
in weight gain and is linked to the increased energy intake and rising BMI trends. In addition to
frequency of eating, the types and amount of food and beverages consumed at an eating occasion
may influence energy intake. Aljuraiban et al. [18] suggest that modifying eating behaviour through
more frequent meals of low energy density and high nutrient quality may be an important approach
to controlling obesity.
A challenge for understanding the contribution of dietary factors is our ability to measure diet.
This is even more difficult in overweight and obese participants who are more prone to misreporting
or underreporting their energy intake [19,20]. In addition, details such as time of eating is important
in examining eating frequency and are difficult to accurately capture with paper-based methods.
Advancement in technology has made available new image-based food recording systems such as
those using a mobile food record app (mFR) [21–25]. Among the advantages of mFRs is the provision
of real-time data capture which allows for the extraction of information from the images on the timing
and location of the eating occasion, without relying on individuals to report these details [22,23]. Thus
the mFR app allows for more accurate capture of time of eating while reducing the burden to the
participant of reporting food consumption [23,24]. A unique aspect of this study was the use of the
mFR to capture frequency of eating and dietary intake.
The objective of this research was to determine the effectiveness of diet supplementation with
the viscous and gel-forming fibre, PolyGlycopleX (PGX), on body weight and composition and to
determine if frequency of eating and diet can explain subsequent changes in 118 overweight adults.
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2. Materials and Methods
2.1. Study Design
A three-arm, parallel, blind, randomised control trial was conducted to determine whether PGX
supplementation would promote weight loss and reduce waist circumference and BMI, change dietary
patterns and reduce the frequency of eating or number of eating occasions. Participants (118 in total)
were divided between three groups, 4.5 g PGX as softgels (PGXS), 5 g PGX granules (PGXG) and 5 g
rice flour (RF) control, (Figure 1) and were assessed at baseline and 12 weeks. This trial was registered
with the Australian New Zealand Clinical Trials Registry (reference ACTRN12614000701628).
The food images sent via the mFR were stored by a participant identification number (ID) only.
No personal information was stored with the images. The research was conducted in accordance
with the principles proposed by the Australian Association for Research in Education (AARE), the
Australian Vice-Chancellor’s Committee (AVCC) and the National Health and Medical Research
Council (NHMRC). The study was conducted in accordance with the Declaration of Helsinki and
ethics approval was granted by the Human Research Ethics Committee, Curtin University (reference
HR170/2014).
2.2. Study Participants
Participants, aged 25–70 years and with BMI 25–35 kg/m2 were recruited through advertisements
on Curtin University radio, as well as email communication systems. Individuals that expressed
interest were screened for eligibility by completing a screening questionnaire. Participants were
excluded if they were: (a) pregnant; (b) unable to complete the 12-week study; (c) undertaking extreme
forms of exercise or dieting; (d) unable to attend the study centre; or (e) had an allergy to any food
ingredient used in the study; (f) had previous or current renal, liver or respiratory failure; (g) had
previous gastric or weight-loss surgery; (h) had any malabsorption conditions or (i) had current
or recent dietary fibre supplementation. The participant flow diagram (Figure 1) lists the reasons
for exclusion. Once assessed as eligible, further details of the study were provided and informed
consent obtained.
2.3. Baseline Assessments
Participants who met the selection criteria had height, weight and waist circumference
anthropometric measurements taken at baseline. A portable stadiometer was used to measure height;
weight was measured using a pre-calibrated digital scale and waist was measured as described by
Norton and Olds [26]. To electronically record food consumption, iPods with mFR application installed
were given to the participants, who were asked to keep a 4-day mFR at baseline and during the twelfth
week of the study.
Before beginning their baseline image-based 4-day food record, all participants received a
30-minute interactive training session by a single researcher who conducted individual or small
group training sessions using PowerPoint slides on how to connect the iPod to the Wi-Fi and how to
use the mFR app. Training sessions were held at Curtin University in a room with Wi-Fi access. The
inclusion of a fiducial marker (a checkerboard pattern of known shape, size and colour) in all food
record images gave a known reference of dimension and markings to assist with food identification
and portion size estimation [25]. During training, participants were able to practice taking before and
after images using food models. Collected food record images were automatically uploaded from
the iPod touch, when in Wi-Fi range. The iPods were coded with the participant ID ensuring each
image was tagged with the participant ID, date and time of eating occasion. Participant ID was used
to identify the images on the server. The server was accessible by researchers only via password.
Prior to the commencement of supplementation and during the twelfth week of the study,
participants took before and after images of all foods and drinks (excluding water) consumed over
four consecutive days. Food consumption during the entire study was ad libitum.
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Figure 1. Participant flow diagram. RF: rice flour.
2.4. PGX Supplementation
The PGXS, PGXG and RF control supplements were provided to participants in a carry bag
containing a 12-week supply labelled with a three-digit code. PGXG and the control were provided
as 5 g individual doses in identical foil sachets and PGXS was provided in plain white jars each
containing one month’s supply. Research staff were blinded to the treatment allocation until all
analyses were completed.
In Arm 1 (PGXS) in tructio s w re provided in writing and verbally to the participants: “Take
1–2 softgels three times a day in , 2–4 softgels three times a d y in week 2 and 4–6 softgels,
three times a day in we k 3 to week 12”. The recommend dose was four (4) to six (6) softgels
containing 0.64 g fibre each, three times a day. This represented a supplement of dietary of between
7.6–11.4 g/day. Participants were also asked to consume 500 mL water with every softgel dose.
Participants in Arm 2 were instructed to consume 5 g of PGXG containing 4.4 g fibre provided in a
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single dose foil sachet taken three times a day just before or with meals over the 12-week intervention
period. This represented a supplement of dietary fibre of 12.2 g/day. Those in Arm 3 were provided
with 5 g of RF containing 4 g fibre in the same dose format as the PGXG, representing 12 g fibre/day.
RF was selected due to its neutral taste and hypoallergenicity, and it has a similar dietary fibre content,
energy, colour and texture to PGX [7]. The recommended dose was 1 sachet, three times per day.
Directions were “Stir 1 sachet into your meal or in a drink and consume immediately. You must
consume 500mL of water each time you take a sachet.” Participants were also advised that “If you
have any discomfort, reduce the dose to 1 sachet a day for week 1, 2 sachets for week 2 and 3 sachets
week 3 to week 12. Contact the researcher to discuss any issues.” Participants were informed of the
importance of consuming water with the supplement as well as the possible gastrointestinal effects
of fibre such as diarrhoea, bloating and flatulence as described in research by Kacinik et al. [7]. All
participants were instructed to record their daily sachet or softgel intake and report in person to the
researcher at the end of week 12 of the intervention.
2.5. Post-Intervention Assessments
At the end of the 12-week intervention period, measurement of participants’ height, weight and
waist circumference were repeated, along with the 4-day mFR being repeated during week 12. At the
end of the 12-week intervention, during the final meeting participants reported the number of doses to
the interviewer and data were recorded in participant files.
2.6. Dietary Analysis
A researcher reviewed the 4-day food record images and as needed, confirmed the content of
images with participants. Eating occasions were defined as all food and beverages (except water) and
were taken from the image metadata and any additional notes supplied by the participant. Eating
occasions were categorised as beverage only, food only, single item, food and beverage or fibre only.
The images of fibre also allowed dose of fibre taken to be determined. Analysis was conducted to
measure any change in eating occasions from baseline to study week 12.
Images were analysed and eating occasions, types of foods and serving sizes were entered into a
database specifically designed to capture the number of eating occasions and food groups according
to the Australian Guide to Healthy Eating food group serves (vegetables, fruit, grain (cereal) foods,
mostly wholegrain and/or high cereal fibre varieties, lean meats and poultry, fish, eggs, tofu, nuts and
seeds and legumes/beans, milk, yoghurt cheese and/or alternatives, mostly reduced fat) (NHMRC
2013) plus junk food (Table 1).
The primary outcome variables measured at baseline and at the end of the intervention were:
changes in weight, waist circumference and BMI; eating occasions and foods consumed each day
classified as serves of junk food (energy-dense nutrient poor), grain (cereal), meat, dairy, fruits and
vegetables for the three intervention groups. Within each intervention group, participants were further
categorised into fibre dose compliance level and number of eating occasions and the primary outcomes
for this subgroup were also evaluated.
2.7. Statistical Analysis
Both intention-to-treat analysis and per-protocol analyses were performed and reported. The
distribution of all outcome variables, weight, waist and BMI were checked by construction of
histograms to check normality. A mixed effect model with clustering of participants’ ID and robust
variance-covariance estimation were used to assess outcome variables. For the intention-to-treat
analysis, all randomised participants were included and all available data at each study time point
were used. For per-protocol analysis, only those who completed the study at week 12 were included
and missing values were not imputed. Further analysis of subgroups by actual dose consumed was
performed and reported. All tests were two tailed and a p value < 0.05 was regarded as statistically
significant. All analyses were performed using Stata MP 14.1 (Stata Corp., College Station, TX, USA).
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Baseline measurements showing of all recruited participant characteristics according to treatment
group are shown in Table 2. There were 92 females and 28 males, evenly distributed across the
three treatment groups. In total 83 of the 118 participants (63% retention) completed the 12-week
study. Greater attrition was observed in the first two weeks of the supplementation for participants
who reported stomach upsets and diarrhoea after PGXG consumption (attrition = 6); who reported
diarrhoea, headaches, difficulty swallowing recommended PGXS dose (attrition = 6) and during the
first six weeks of supplementation in the RF group (attrition = 15) due to constipation and feeling ill.
Baseline data (Table 2) shows the characteristics of study participants randomised (n = 118) and
shows that at baseline there were no significant differences (p > 0.05) in age, height, weight, waist
circumference, BMI and food group servings across three groups. At baseline PGXS participants had
similar baseline frequency of eating (number of eating occasions) to the PGXG and RF participants but
those allocated to the PGXG intervention had a significantly greater number of eating occasions per
day than those allocated to the RF intervention (p = 0.04) (Table 2).
Table 2. Characteristics of all recruited study participants randomised at baseline (n = 120)
comparing groups.
All Participants PGXS (n = 40) PGXG (n = 40) RF (n = 40)
Men 9 10 9
Women 31 30 31
Mean ± SD
Age (years) 42.2 ± 16.0 46.5 ± 14.0 43.3 ± 16.8
Height (cm) 167.4 ± 9.1 167.3 ± 9.0 166.4 ± 7.9
Weight (kg) 82.7 ± 16.8 80.9 ± 16.6 81.3 ± 17.7
Waist (cm) 89.8 ± 12.8 90.7 ± 12.1 88.4 ± 14.3
Body Mass Index (BMI, kg/m2) 29.4 ± 4.8 28.7 ± 4.4 29.2 ± 4.8
Eating occasions per day 5.4 ± 2.8 6.3 ± 2.0 4.8 ± 2.1
Food group servings (mean daily serves ± SD)
Fruit (150 g) 0.8 ± 0.8 1.0 ± 1.0 1.1 ± 1.2
Vegetable (75 g) 2.4 ± 1.5 2.6 ± 1.4 2.5 ± 1.1
Grain (cereal) (40 g bread, 75–120 g cooked rice, pasta etc. or 500 kJ) 3.8 ± 1.8 4.3 ± 2.2 4 .0 ± 1.5
Dairy (250 mL milk, 40 g cheese or 500–600 kJ) 1.3 ± 0.9 1.6 ± 0.8 1.3 ± 0.8
Junk food (60 g meat pie or hot chips, 40 g donut or cake) 3.5 ± 1.9 3.1 ± 1.6 3.0 ± 1.7
Meat (65 g meat, 100 g fish or 500–699 kJ) 1.0 ± 0.7 1.6 ± 0.8 1.4 ± 0.7
Alcohol (150 mL) 0.5 ± 0.8 0.4 ± 0.5 0.1 ± 0.2
PGXS = PGX softgel, PGXG = PGX granules, RF = Rice Flour. SD = Standard Deviation.
3.1.2. Per-Protocol Analysis
Baseline measurements according to treatment group showing participant characteristics of all
who consumed the recommended dose of fibre supplements are shown in Table 3. Baseline data
(Table 3) shows the characteristics of study participants (n = 54) and shows that at baseline there were
no significant differences (p > 0.05) in weight, waist circumference and BMI across three groups. PGXG
and RF intervention sub-group numbers of eating occasions per day were not significantly different to
each other or to the baseline group but the PGXS subgroup number of eating occasions was 7.4 times
per day (Table 3).
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Table 3. Characteristics of study participants randomised at baseline (n = 54) comparing subgroups
who consumed the recommended dose of fibre supplements.
All Participants PGXS (n = 17) PGXG (n = 18) RF (n = 17) p Value
Body weight (kg) 76.5 ± 15.9 87.7 ± 20.2 78.3 ± 15.0 0.62
BMI (kg/m2) 27.2 ± 4.5 28.7 ± 5.2 28.3 ± 5.2 0.64
Waist (cm) 84.8 ± 12.2 89.2 ± 20.4 87.1 ± 13.8 0.59
Eating occasions
per day 7.4 ± 2.5 6.0 ± 2.0 5.5 ± 2.6 p > 0.05
PGXS = PGX softgel, PGXG = PGX granules, RF = Rice Flour.
3.2. Effect of Intervention on Body Weight and Body Composition
3.2.1. Intention-to-Treat Analysis
Intention-to-treat analysis revealed a significant reduction in waist circumference at week 12 of
minus 2.5cm (Confidence Interval = −3.9, −0.8, p = 0.003) for those in the PGXG group (Table 4). No
effect was seen on waist circumference for the PGXS and RF groups (p > 0.05). There was no effect of
the PGXS or PGXG interventions on weight and BMI.
3.2.2. Per-Protocol Analysis
Per-protocol analyses of the subgroup who consumed the recommended dose of fibre supplements
showed a significant weight loss and reduction in BMI in the PGXG intervention compared to baseline
(Table 5). However, the PGXS subgroup did not show a significant weight change during the
intervention period. Compared to effect of the intervention on weight seen in the RF subgroup,
that of the PGXG subgroup was significantly greater (p = 0.001).
Table 4. Change in participant characteristics from baseline to week 12 of the interventions of all
participants who completed the interventions (intention-to-treat analysis).
All Participants PGXS (n = 32) PGXG (n = 32) RF (n = 19)
Body weight (kg) 0.47 ± 1.85 −0.49 ± 0.34 −0.03 ± 0.58
BMI (kg/m2) 0.15 ± 0.65 −0.17 ± 0.13 0.01 ± 0.20
Waist (cm) −0.17 ± 2.92 −2.50 ± 0.60 p = 0.03 −1.3 ± 1.0
Eating occasions per day −0.60 ± 1.5 −0.82 ± 1.28 p = 0.01 −0.22 ± 1.72
Food group servings
(mean daily serves ± SD)
Fruit (150 g) 1 −0.2 ± 0.76 0.08 ± 0.7 −0.18 ± 0.75
Vegetable (75 g) 1 −0.07 ± 1.11 −0.34 ± 1.22 −0.23 ± 0.64
Grain (cereal) 0.21 ± 1.73 −0.79 ± 1.66 −0.51 ± 1.23
Dairy 0.11 ± 0.63 −0.22 ± 0.64 0.07 ± 0.35
Junk food −0.14 ± 2.00 −0.57 ± 1.29 0.28 ± 2.12
Meat 0.08 ± 0.59 0.01 ± 0.79 −0.09 ± 0.78
Alcohol −0.22 ± 0.73 0.17 ± 0.99 −0.02 ± 0.26
Fibre (3.8–4.4 g) 1 1.89 ± 0.91 2.17 ± 0.71 2.35 ± 0.58
Bold values denote significant within treatment effect. PGXS = PGX softgel, PGXG = PGX granules, RF = Rice Flour.
1 1 serve of fruit = 150 g, 1 serve vegetable = 75 g, 1 serve fibre = 3.8 to 4.4 g.
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Table 5. Change in participant characteristics from baseline to week 12 of the PGXS, PGXG and
RF interventions in the subgroup analysis of those who consumed the recommended dose of fibre
supplements (per-protocol analysis).
All Participants PGXS (n = 17) PGXG (n = 18) RF (n = 17)
Body weight (kg) 0.22 ± 1.61 −1.4 ± 0.10 p < 0.01 −0.03 ± 0.58
BMI (kg/m2) 0.07 ± 0.59 −0.5 ± 0.10 p < 0.01 0.01 ± 0.20
Waist (cm) −1.04 ± 2.28 −1.2 ± 1.00 −1.3 ± 1.0
Eating occasions per day −1.3 ± 1.9 −1.4 ± 1.20 p < 0.01 −0.22 ± 1.72
Food group servings
(mean daily serves ± SD)
Fruit (150 g) −0.43 ± 0.59 −0.63 ± 0.57 p = 0.022 −0.18 ± 0.75
Vegetable (75 g) −0.35 ± 0.96 −0.82 ± 1.31 −0.23 ± 0.64
Grain (cereal) −0.93 ± 1.47 −1.52 ± 1.84 p = 0.019 −0.51 ± 1.23
Dairy −0.05 ± 0.56 −0.59 ± 0.50 p = 0.012 0.07 ± 0.35
Junk food −0.17 ± 1.48 −0.76 ± 0.85 0.28 ± 2.12
Meat −0.06 ± 0.62 0.18 ± 0.90 −0.09 ± 0.78
Alcohol −0.50 ± 0.98 0.11 ± 0.32 −0.02 ± 0.26
Fibre supplement serves
(serving size 4.5–5 g) 2.6 ± 0.47 2.82 ± 0.24 2.35 ± 0.58
Bold values denote significant within treatment effect. PGXS = PGX softgel, PGXG= PGX granules, RF = Rice Flour.
SD = standard deviation.
3.3. Number of Eating Occasions and Food Group Servings
Collection of mFR images required participants to use the iPod provided by the study to record
images before and after each eating occasion during the 4-day food record (Figure 2).
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Figure 2. Before and after images of an eati g occasio ith foil sachet contai ing PGXG and fiducial
marker captured with the mobile fo d record Ap i .
3.3.1. Intention-to-Treat Analysis
Analysis was conducted to measure change in number of eating occasions from baseline to week
12 of the interventions. The number of eating occasions was significantly reduced in the PGXG group
(p = 0.01) during the intervention (Table 4). No significant differences in number of eating occasions
between baseline and week 12 were observed in the groups PGXS and RF or in food group servings in
any of the intervention groups (Table 4) in the intention-to-treat analyses.
3.3.2. Per-Protocol Analysis
For the per-protocol analysis, the subgroup who consumed PGXG at the recommended dose of
2.5 to 3 times per day, significantly reduced their eating occasions by 1.4 ± 1.2 (CI −2.1, −0.6, p < 0.01)
during the intervention period (Table 5).
Likewise, the participants who consumed PGXG at the recommended dose significantly reduced
their daily intake of fruit (−0.63 ± 0.57 serves, p = 0.02), dairy (−0.59 ± 0.50 serves, p = 0.01) and grain
food (−1.52 ± 1.84 serves, p = 0.02) during the intervention (Table 5). Analysis of types of foods in
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the mFR showed that 1.6 to 2 serves of the grain food consumed at baseline were white bread for
these participants. This consumption of white bread for the PGXG group also dropped significantly to
0.74 serves per day at 12 weeks of intervention.
3.4. Adverse Events
Adverse effects reported by the participants were mild and agreed with common reported
reactions to increased fibre, for example those reported by Kacinik et al. (2011) [7] where for PGX
supplementation, 30.9 % of participants reported diarrhoea, bloating and flatulence whereas for rice
flour consumption 7.8% reported constipation.
4. Discussion
This 12 week randomised controlled study showed that when consumed at the recommended
dose (per-protocol), the PGXG intervention gave a reduction in BMI and body weight, the number of
eating occasions per day and consumption of servings of grain food.
The weight loss and BMI reduction observed for the PGXG per-protocol intervention is most
likely a result of compliance to the recommended dose, resulting in 64% of participants who consumed
PGXG at the recommended dose losing weight and reducing BMI. The average 1.4-kg weight loss
found in our study of overweight adults for the PGX per-protocol intervention is in agreement with
previous research by Lyon et al. [28] who found a weight loss in women of 1.6 kg with 12 weeks PGX
supplementation. Pal et al. [29] reported obese adults on 12-week supplementation of both artificially
sweetened and flavoured PGX and psyllium lost weight (1.6 kg and 1.1 kg respectively).
On an individual basis, the highest weight loss in the PGXS group (intention-to-treat) was 4.4 kg,
with a waist circumference decrease of 5.5 cm. However, in this group a weight gain of 6.3 kg and
waist circumference increase was 9.6 cm was also recorded in one participant. This high variance in
change in weight and waist circumference resulted in a non-significant weight loss for this group. Data
collected by personal communication at the 6-week visit showed five participants in the PGXS group
reporting that they expected PGXS to be a “magic bullet” for weight loss, which was an unexpected
issue that requires consideration in future research. Protocol in future research may involve education
of participants on using PGX to control appetite.
The significant reduction in waist circumference observed in the present study for PGXG
intention-to-treat group of 2.5 cm was similar in magnitude to that reported in a study by
Reimer et al. [8] where PGX consumption over 14 weeks resulted in a significant reduction of 1.96 cm
in waist circumference. The significant reduction in BMI of 0.5 observed in the present study for PGXG
per-protocol sub-group was in contrast to Reimer [8] who found no significant differences in BMI
compared to baseline.
The findings from our study that PGXS and PGXG consumption (intention-to-treat groups) did
not affect weight is similar to research on PGX consumption by Kacinik et al. [7] who reported no
significant differences in weight loss between PGX and the placebo groups in a study involving a
low-calorie diet of 1000 kcal/day for both treatments. There was also no weight loss recorded in a
three-week study by Reimer et al. [30] where PGX was pre-mixed with breakfast cereal and consumed
with yogurt. In our study participants were not on an energy restricted diet nor were the PGX and RF
doses mixed with other products.
The use of the mFR allowed our research to determine level of compliance to the recommended
dose of the PGXG per-protocol group by reviewing the images collected. The mFR image analysis of
the foods eaten, serving sizes and number of eating occasions per day enabled important information
about the dietary pattern of the overweight participants to be collected. The reduced number of eating
occasions found with the PGXG per-protocol subgroup, translated into reduced consumption of grain
food of 1.52 serves (p = 0.019), mainly being a reduction in consumption of white bread.
Research by Kerr et al. [23] reported a reduction in consumption of energy-dense nutrient-poor
(EDNP) foods as a result of tailored dietary feedback using the mFR. In the present study there was
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a non-significant reduction in junk food consumption of 0.57 in the PGXG intention-to-treat group
and 0.76 serves in the PGXG per-protocol group. Pollard et al. [31] also found overweight people were
more likely than those who were a healthy weight to decrease their intake grain food when trying
to lose weight, supporting the reduced grain food trend found in this research. Small reductions in
conscious or mindful energy intake can improve weight gain [32] and the choice to reduce grain food
intake found in this research may have been the contributor to weight loss. Although we observed a
reduction in daily intake of fruit and dairy, which is not desirable based on dietary guidelines [27], the
magnitude of this change was minor.
Data from the mFR showed participants in all groups, other than the PGXG per-protocol
subgroup, appeared to make no changes to their eating pattern, as after 12 weeks of intervention, food
group servings were not significantly different to baseline. This finding is supported by previous
studies [32–34] where it was reported that humans tend to consume a consistent weight or volume
of food from day to day. While participants reported feeling full in previous PGXS and PGXG
research [9,10,35,36], most participants in this study did not appear to use appetite to change their
eating patterns, except in the per-protocol PGXG group who consumed the recommended dose, most
likely resulting reduced appetite and reduced food intake.
Dietary feedback using the mFR indicated a reduction of 1 serve white bread, each day, which may
have been a contributor to the reduction of 40 g in weight daily in the PGXG per-protocol group [27].
In a previous study, a reduction of 31.5 g carbohydrate per day was recorded at 12 weeks after PGX
supplementation using a 3-day food and drink diary [29]. The 3-day food and drink diary does not
provided details on type carbohydrates foods, whereas the mFR reports provided detail of types of
foods and serving sizes. Dietary intake records collected using the mFR can reduce the bias found in
auto-assessment [24].
In the present study, PGXG was taken with 500 mL water immediately before or with a meal.
The PGXG was mixed in the water, in juice or mixed into the meal. The mechanism for weight loss in
the PGXG per-protocol sub-group in the present study may have been as a result of reducing dietary
energy density of the meals with which it was consumed by increasing the fibre and water content of
meals while maintaining the volume of food eaten [37,38]. Decreasing dietary energy density has been
shown to be useful in long-term weight loss [39].
The detailed dietary feedback from the mFR enabled this research to determine weight loss was
possible when PGXG at the recommended dose was consumed and the reduction in the number
of eating occasions may be part of the mechanism for this effect. Previous research indicates that a
possible mechanism behind the appetite and body weight reduction effects of PGX may be related
to circulating gut hormones [30]. Reimer et al. [30] reported increased peptide YY, which can slow
gastric emptying and decreased ghrelin (an appetite stimulant) on consumption of PGX. More work is
required to confirm the physiological mechanisms controlling these effects of PGX.
The detailed dietary feedback from the mFR enabled this research to more accurately determine
food group changes after 12 weeks. The reason the PGXS, and PGXG per-protocol groups did not
reduce their weight may be because they did not reduce the number of eating occasions or change
their daily intake of the foods and continued to consume the amount and type of food usually eaten.
In addition, research by Polidori et al. [40] reports that weight loss leads to increased appetite, and
appetite increases by approximately 100 kcal/day per kg of lost weight. The reason fibre such as PGXG
helps some individuals in the control of appetite and not others requires more research.
Limitation
Meals and consumption of test products were self-administered; the possibility of non-compliance
could not be avoided. In the current study misreporting of intake may have occurred due to participants
not taking images of all food and beverages consumed. In addition, the assessment of food group
serves by a trained analyst may not be sensitive enough to detect changes in dietary intake.
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5. Conclusions
Supplementation with PGX at the recommended dose resulted in a reduction in body weight (kg),
BMI (kg/m2), reduced frequency of eating and reduced intake of white bread. The weight loss and
BMI reduction from baseline to 12 weeks was significantly greater for PGXG at the recommended
dose than for the RF treatment. Dietary assessment using the mFR provided detailed information
enabling accurate analysis of the number of eating occasions and changes to food group servings
per day. Further research on reducing the frequency eating of specific foods, such as junk food is
warranted. These results demonstrate the potential benefits of PGX fibre in controlling frequency of
eating and in weight loss.
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